ATE476527T1 - Quantifizierungsverfahren für die vegf isoformen einer biologischen probe - Google Patents

Quantifizierungsverfahren für die vegf isoformen einer biologischen probe

Info

Publication number
ATE476527T1
ATE476527T1 AT05772016T AT05772016T ATE476527T1 AT E476527 T1 ATE476527 T1 AT E476527T1 AT 05772016 T AT05772016 T AT 05772016T AT 05772016 T AT05772016 T AT 05772016T AT E476527 T1 ATE476527 T1 AT E476527T1
Authority
AT
Austria
Prior art keywords
biological sample
quantification methods
vegf isoforms
vegf121
patient
Prior art date
Application number
AT05772016T
Other languages
English (en)
Inventor
Fabien Calvo
Samia Mourah
Benyoussef Naimi
Original Assignee
Inst Nat Sante Rech Med
Assist Publ Hopitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Assist Publ Hopitaux De Paris filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE476527T1 publication Critical patent/ATE476527T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT05772016T 2004-06-14 2005-06-14 Quantifizierungsverfahren für die vegf isoformen einer biologischen probe ATE476527T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04291485A EP1607485A1 (de) 2004-06-14 2004-06-14 Quantifizierungsverfahren für die VEGF-121 Isoform in einer biologischen Probe
PCT/EP2005/007066 WO2005121362A2 (en) 2004-06-14 2005-06-14 Method for selectively quantifying vegf isoforms in a biological sample and uses thereof.

Publications (1)

Publication Number Publication Date
ATE476527T1 true ATE476527T1 (de) 2010-08-15

Family

ID=34931177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05772016T ATE476527T1 (de) 2004-06-14 2005-06-14 Quantifizierungsverfahren für die vegf isoformen einer biologischen probe

Country Status (5)

Country Link
US (1) US8530162B2 (de)
EP (2) EP1607485A1 (de)
AT (1) ATE476527T1 (de)
DE (1) DE602005022709D1 (de)
WO (1) WO2005121362A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913697B2 (en) 2001-02-14 2005-07-05 Science & Technology Corporation @ Unm Nanostructured separation and analysis devices for biological membranes
EP2359689B1 (de) 2002-09-27 2015-08-26 The General Hospital Corporation Mikrofluid-Vorrichtung zur Zelltrennung, sowie Verwendung derselben
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
CN101277704A (zh) 2005-04-12 2008-10-01 因特拉迪格姆公司 用于治疗癌症及其它新血管生成疾病的RNAi治疗剂的组合物和方法
US7893244B2 (en) 2005-04-12 2011-02-22 Intradigm Corporation Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20080070792A1 (en) 2006-06-14 2008-03-20 Roland Stoughton Use of highly parallel snp genotyping for fetal diagnosis
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
EP2334812B1 (de) 2008-09-20 2016-12-21 The Board of Trustees of The Leland Stanford Junior University Nichtinvasive diagnose von fötaler aneuploidie mittels sequenzieren
EP2309271A1 (de) 2009-09-25 2011-04-13 INSERM (Institut National de la Santé et de la Recherche Medicale) Verfahren zur Vorhersage der Reaktionsfähigkeit eines Tumorpatienten auf eine Behandlung mit einem Tyrosinkinasehemmer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922855A (en) * 1993-12-17 1999-07-13 Oregon Health Sciences University Mammalian DNA mismatch repair genes MLH1 and PMS1
EP1770164B1 (de) * 1996-10-31 2010-09-01 Human Genome Sciences, Inc. Streptococcus pneumoniae-Antigene und Impfstoffe
AU9550198A (en) * 1997-10-21 1999-05-10 University Court Of The University Of Glasgow, The Jmy, a co-activator for p300/cbp, nucleic acid encoding jmy and uses thereof
EP1016727A1 (de) * 1998-12-30 2000-07-05 Introgene B.V. Gentherapie zur Förderung der Angiogenese
AU2003240795A1 (en) * 2002-05-24 2003-12-12 Invitrogen Corporation Nested pcr employing degradable primers
ES2429338T3 (es) * 2002-12-23 2013-11-14 Vical Incorporated Vacuna basada en polinucleótidos optimizados por codones contra infección por citomegalovirus humano

Also Published As

Publication number Publication date
EP1759018A2 (de) 2007-03-07
US20100167273A1 (en) 2010-07-01
US8530162B2 (en) 2013-09-10
EP1607485A1 (de) 2005-12-21
WO2005121362A2 (en) 2005-12-22
EP1759018B1 (de) 2010-08-04
DE602005022709D1 (de) 2010-09-16
WO2005121362A3 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
ATE476527T1 (de) Quantifizierungsverfahren für die vegf isoformen einer biologischen probe
WO2007025044A3 (en) Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
DK1889059T3 (da) Fremgangsmåde til forbedret immunoassay
DE602007003833D1 (de) Verbesserte vitamin-d-messung
ATE476657T1 (de) Vorhersage von letalität und detektion von schweren erkrankungen
DE602005015894D1 (de) Diagnostische testvorrichtung
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
JP2009501333A5 (de)
DE602004030586D1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
EP2770328A3 (de) Verfahren zur Diagnose von Bauchspeicheldrüsenkrebs
RU2008103988A (ru) Способ диагностики рассеяного склероза
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
EP1898215A4 (de) Verfahren zum testen endokriner substanz in proben
NZ592819A (en) Thyroid analyte detection and measurement
WO2005093103A3 (en) Development and use of fluorescent probes of unbound analytes
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
NO20034059L (no) Fremgangsmate for screening av pre-diabetiske tilstander og screening-reagens
WO2010027260A3 (en) Biomarkers for identifying subjects predisposed to developing insulin resistance and determining the insulin resistance status
IL137308A0 (en) Conductivity-normalized urinary analyte concentration measurement for use in disease diagnosis
ATE483983T1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
AR055411A1 (es) Metodo para diagnosticar la hipertension.
WO2005005957A3 (en) Method of detecting cancer using delta-catenin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties